UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Details
Sales, net (notes 1, 3, 9 and 11)	$ 46,904	$ 41,998	$ 41,414
Cost of goods sold	17,438	15,692	15,019
Gross profit	29,466	26,306	26,395
Sales and marketing	1,738	1,708	1,544
Research and development	483	454	447
General and administrative	9,613	5,447	5,393
Operating income	17,632	18,697	19,011
Dividend and interest income	254	217	17
Gains and (losses) on investments	0	32	0
Royalty income (note 12)	6	76	86
Other, net	(8)	437	(32)
Income before provision for income taxes	17,884	19,459	19,082
Provision for income taxes (note 7)	3,157	904	10,577
Net income	$ 14,727	$ 18,555	$ 8,505
Earnings per common share (basic) (note 1)	$ 3.96	$ 4.97	$ 2.29
Earnings per common share (diluted) (note 1)	$ 3.94	$ 4.95	$ 2.28
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ 1,507	$ (2,949)	$ 3,893
Unrealized gain on investments net of taxes of $0, $0 and $6	0	0	10
Total comprehensive income	$ 16,234	$ 15,606	$ 12,408